Global Research at UCSF
contact info
  • Resources
    • About the Forum
    • UCSF Programs
    • Scholars Resource Center
    • Partners Abroad
    • UCSF Affiliated Organizations
  • Admin Forum
    • Health/Insurance Forum
    • Grant Management Forum
    • Connectivity Forum
    • IRB Forum
    • Budgeting Forum
    • Shipping forum
  • Interest Group
    • Alcohol and HIV Interest
    • East Africa Interest Group >
      • Kenya Forum
      • Tanzania Forum
      • Uganda Forum
    • Global Health Economics
    • Global Hospitalists
    • Global Maternal & Newborn
    • Global Nursing
    • Global Oncology
    • Global Oral Health
    • Global Pediatrics Interest
    • Global Surgery
    • Global Vision
    • India Interest Group >
      • India/Southeast Asia
    • Infectious Disease Implementation Science
    • Diagnostics
    • Disaster Response
    • Refugee Health
    • Malaria Interest
    • Young Investigators in International Research
  • Work Group
    • UCSF East Africa Scientific Meeting
    • East Africa Office
    • Global JrFaculty
    • International Research Advisory Committee
    • Travel Health & Safety
    • GHS Alumni
  • Newsletter

Philip Rosenthal

7/21/2014

0 Comments

 
Picture
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine. Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P. falciparum multidrug resistance 1 (pfmdr1) genes are associated with decreased sensitivity to amodiaquine and lumefantrine, but effects of these polymorphisms on therapeutic responses to artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) have not been clearly defined. Individual patient data from 31 clinical trials were harmonized and pooled by using standardized methods from the WorldWide Antimalarial Resistance Network. Data for more than 7,000 patients were analyzed to assess relationships between parasite polymorphisms in pfcrt and pfmdr1 and clinically relevant outcomes after treatment with AL or ASAQ.

0 Comments



Leave a Reply.

    Author

    GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide

    Archives

    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013

    Categories

    All
    HIV

    RSS Feed

UCSF Global Projects worldwide

Picture
Learn about UCSF Research across the globe.

UCSF Global Health Sciences (GHS)

Picture
UCSF Global Health Sciences
Our mothership.

Picture

Travel Health & Safety links

Picture

UCSF Global HUB

Picture
Compliance & logistics for global research

CTSI- Global Health Program

Picture
Tap into expertise at UCSF

✕